Literature DB >> 21303352

The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression.

O S Cohen1, I Prohovnik, A D Korczyn, L Ephraty, Z Nitsan, R Tsabari, S Appel, H Rosenmann, E Kahana, J Chapman.   

Abstract

OBJECTIVES: To develop a scale sensitive for the neurological manifestations of Creutzfeldt-Jakob disease (CJD).
METHODS: A 26-item CJD neurological status scale (CJD-NS) was created based on characteristic disease manifestations. Each sign was assigned to one of eight neurological systems to calculate a total scale score (TSS) and a system involvement score (SIS). The scale was administered to 37 CJD patients, 101 healthy first-degree relatives of the patients and 14 elderly patients with Parkinson's disease (PD).
RESULTS: The mean TSS (±SD) was significantly higher in patients with CJD (13.19 ± 5.63) compared with normal controls (0.41 ± 0.78) and PD patients (9.71 ± 3.05). The mean SIS was also significantly different between the CJD (5.19 ± 1.22) and PD (2.78 ± 1.18 P ≤ 0.01) groups reflecting the disseminated nature of neurological involvement in CJD. Using a cutoff of TSS > 4 yielded a sensitivity of 97% for CJD, and specificity of 100% against healthy controls. All individual items showed excellent specificity against healthy subjects, but sensitivity was highly variable. Repeat assessments of CJD patients over 3-9 months revealed a time-dependent increase in both the TSS and the SIS reflecting the scale's ability to track disease progression.
CONCLUSIONS: The CJD-NS scale is sensitive to neurological signs and their progression in CJD patients.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21303352      PMCID: PMC3100358          DOI: 10.1111/j.1600-0404.2011.01489.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  25 in total

1.  AN ATAXIC FORM OF SUBACUTE PRESENILE POLIOENCEPHALOPATHY (CREUTZFELDT-JAKOB DISEASE).

Authors:  B BROWNELL; D R OPPENHEIMER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-08       Impact factor: 10.154

2.  First symptom in sporadic Creutzfeldt-Jakob disease.

Authors:  G D Rabinovici; P N Wang; J Levin; L Cook; M Pravdin; J Davis; S J DeArmond; N M Barbaro; J Martindale; B L Miller; M D Geschwind
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

3.  New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests.

Authors:  M Zeidler; G E Stewart; C R Barraclough; D E Bateman; D Bates; D J Burn; A C Colchester; W Durward; N A Fletcher; S A Hawkins; J M Mackenzie; R G Will
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

Review 4.  Does the presentation of Creutzfeldt-Jakob disease vary by age or presumed etiology? A meta-analysis of the past 10 years.

Authors:  Brian S Appleby; Kristin K Appleby; Peter V Rabins
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

5.  Diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  H A Kretzschmar; J W Ironside; S J DeArmond; J Tateishi
Journal:  Arch Neurol       Date:  1996-09

6.  Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease.

Authors:  S T MacDonald; K Sutherland; J W Ironside
Journal:  Neuropathol Appl Neurobiol       Date:  1996-08       Impact factor: 8.090

7.  Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis.

Authors:  Christopher A Wall; Teresa A Rummans; Allen J Aksamit; Lois E Krahn; V Shane Pankratz
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

8.  MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study.

Authors:  R K Fulbright; C Hoffmann; H Lee; A Pozamantir; J Chapman; I Prohovnik
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-17       Impact factor: 3.825

9.  The Heidenhain variant of Creutzfeldt-Jakob disease.

Authors:  S Kropp; W J Schulz-Schaeffer; M Finkenstaedt; C Riedemann; O Windl; B J Steinhoff; I Zerr; H A Kretzschmar; S Poser
Journal:  Arch Neurol       Date:  1999-01

10.  Intracerebral distribution of infectious amyloid protein in spongiform encephalopathy.

Authors:  P Brown; K Kenney; B Little; J Ironside; R Will; L Cervenáková; R J Bjork; R A San Martin; J Safar; R Roos
Journal:  Ann Neurol       Date:  1995-08       Impact factor: 10.422

View more
  7 in total

1.  Disease duration in E200K familial Creutzfeldt-Jakob disease is correlated with clinical, radiological, and laboratory variables.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Zeev Nitsan; Shmuel Appel; Esther Kahana; Hanna Rosenmann; Chen Hoffmann
Journal:  J Neural Transm (Vienna)       Date:  2018-11-29       Impact factor: 3.575

2.  Characterization of sleep disorders in patients with E200K familial Creutzfeldt-Jakob disease.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Naama Warman-Alaluf; Yael Orlev; Gili Givaty; Zeev Nitsan; Shmuel Appel; Hanna Rosenmann; Esther Kahana; Dalia Shechter-Amir
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

3.  Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Zeev Nitsan; Shmuel Appel; Chen Hoffmann; Hanna Rosenmann; Esther Kahana; Hedok Lee
Journal:  J Neurol       Date:  2014-12-19       Impact factor: 4.849

4.  Clinical radiological correlation in E200K familial Creutzfeldt-Jakob disease.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Oliver L Siaw; Naama Warman-Alaluf; Zeev Nitsan; Shmuel Appel; Esther Kahana; Hanna Rosenmann; Chen Hoffmann
Journal:  J Neural Transm (Vienna)       Date:  2016-09-13       Impact factor: 3.575

5.  Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease.

Authors:  Leo H Wang; Robert C Bucelli; Erica Patrick; Dhanashree Rajderkar; Enrique Alvarez Iii; Miranda M Lim; Gabriela Debruin; Victoria Sharma; Sonika Dahiya; Robert E Schmidt; Tammie S Benzinger; Beth A Ward; Beau M Ances
Journal:  J Neurol       Date:  2012-09-12       Impact factor: 4.849

6.  Unusual presentations in patients with E200K familial Creutzfeldt-Jakob disease.

Authors:  O S Cohen; I Kimiagar; A D Korczyn; Z Nitsan; S Appel; C Hoffmann; H Rosenmann; E Kahana; J Chapman
Journal:  Eur J Neurol       Date:  2016-01-25       Impact factor: 6.089

7.  Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob disease.

Authors:  Akin Nihat; Tze How Mok; Hans Odd; Andrew Geoffrey Bourne Thompson; Diana Caine; Kirsty McNiven; Veronica O'Donnell; Selam Tesfamichael; Peter Rudge; John Collinge; Simon Mead
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-01-12       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.